Predicting risk of adverse drug reactions in older adults
Reads0
Chats0
TLDR
Good clinical practice for detecting and predicting ADRs in vulnerable patients includes detailed documentation and regular review of prescribed and over-the-counter medications through standardized medication reconciliation.Abstract:
Adverse drug reactions (ADRs) are common in older adults, with falls, orthostatic hypotension, delirium, renal failure, gastrointestinal and intracranial bleeding being amongst the most common clinical manifestations. ADR risk increases with age-related changes in pharmacokinetics and pharmacodynamics, increasing burden of comorbidity, polypharmacy, inappropriate prescribing and suboptimal monitoring of drugs. ADRs are a preventable cause of harm to patients and an unnecessary waste of healthcare resources. Several ADR risk tools exist but none has sufficient predictive value for clinical practice. Good clinical practice for detecting and predicting ADRs in vulnerable patients includes detailed documentation and regular review of prescribed and over-the-counter medications through standardized medication reconciliation. New medications should be prescribed cautiously with clear therapeutic goals and recognition of the impact a drug can have on multiple organ systems. Prescribers should regularly review medication efficacy and be vigilant for ADRs and their contributory risk factors. Deprescribing should occur at an individual level when drugs are no longer efficacious or beneficial or when safer alternatives exist. Inappropriate prescribing and unnecessary polypharmacy should be minimized. Comprehensive geriatric assessment and the use of explicit prescribing criteria can be useful in this regard.read more
Citations
More filters
Journal ArticleDOI
Association of Sex, Age, and Comorbidities with Mortality in COVID-19 Patients: A Systematic Review and Meta-Analysis.
TL;DR: Implementing adequate protection and interventions for COVID-19 patients in general and in particular male patients with age ≥50 years having comorbidities may significantly reduce risk of mortality associated with CO VID-19.
Journal ArticleDOI
Current and future perspectives on the management of polypharmacy
Mariam Molokhia,Azeem Majeed +1 more
TL;DR: There is considerable scope to improve the quality of prescribing and reduce risks from poly-pharmacy using non-medical groups such as pharmacists, specialist nurses and physician assistants, and developments such as the introduction of artificial intelligence and clinical decision support systems also have the potential to improve prescribing and minimise the risks.
Journal ArticleDOI
Facilitating the ethical use of health data for the benefit of society: electronic health records, consent and the duty of easy rescue.
TL;DR: It is argued that the duty of easy rescue—the principle that persons should benefit others when this can be done at no or minimal risk to themselves—grounds the removal of consent requirements for minimally risky records-based research.
Journal ArticleDOI
Prediction of Hospitalization due to Adverse Drug Reactions in Elderly Community-Dwelling Patients (The PADR-EC Score).
Nibu Parameswaran Nair,Leanne Chalmers,Michael Connolly,Michael Connolly,Bonnie J Bereznicki,Gregory M. Peterson,Colin Curtain,Ronald L. Castelino,Luke Bereznicki +8 more
TL;DR: The number of antihypertensives was the strongest predictor of an ADR followed by presence of dementia, renal failure, drug changes in the preceding 3 months and use of anticholinergic medications; these variables were used to derive the ADR prediction score.
Journal ArticleDOI
Explicit criteria as clinical tools to minimize inappropriate medication use and its consequences.
TL;DR: The most widely used sets of explicit PIM criteria to address inappropriate polypharmacy are described with particular focus on STOPP/START criteria and FORTA criteria which have been associated with positive patient-related outcomes when used as interventions in recent randomized controlled trials.
References
More filters
Journal ArticleDOI
Sex Differences in Drug Disposition
TL;DR: This paper summarizes sex differences that impact drug disposition and includes a general comparison of clinical pharmacology as it applies to men and women.
Journal ArticleDOI
Clinical pharmacogenetics implementation consortium guidelines for CYP2C9 and HLA-B genotypes and phenytoin dosing.
Kelly E. Caudle,Allan E. Rettie,Michelle Whirl-Carrillo,L H Smith,Scott Mintzer,Ming Ta Michael Lee,Ming Ta Michael Lee,Teri E. Klein,John T. Callaghan,John T. Callaghan +9 more
TL;DR: In this article, the authors summarize evidence from the published literature supporting these associations and provide recommendations for the use of phenytoin based on CYP2C9 and/or HLA-B genotype (also available on PharmGKB: http://www.pharmgkb.org).
Journal ArticleDOI
Adverse drug reaction risk factors in older outpatients.
Emily R. Hajjar,Emily R. Hajjar,Joseph T. Hanlon,Margaret B. Artz,Catherine I. Lindblad,Catherine I. Lindblad,Carl F. Pieper,Richard Sloane,Christine M. Ruby,Christine M. Ruby,Kenneth E. Schmader +10 more
TL;DR: An expert panel was able to reach a consensus on potential risk factors that increase the risk for ADRs in older outpatients.
Journal ArticleDOI
Prevalence and Risk of Potential Cytochrome P450–Mediated Drug-Drug Interactions in Older Hospitalized Patients with Polypharmacy
TL;DR: The prevalence of potential CYP-mediated DDIs is high in geriatric patients with polypharmacy and the risk of DDIs increases as a function of the number of medications dispensed, but may be facilitated by a single multicomponent, multidrug potential CYp-mediated DDI assessment.